Alzheimer’s Disease Related Content
Jeff talks to Dr. Brent Forester about dementia and other cognitive disorders that are often found in older populations. They discuss the basics of Alzheimer’s disease and other dementias, how to navigate treatment and support a loved one living with these conditions, and some of the current...
The world is aging. According to the World Health Organization , we can expect the over-60 population to double worldwide between 2015 and 2050. Considering 15% of these individuals struggle with some form of mental health disorder, and that neurological and mental issues account for more than 6% of...
Drs. Stephanie Collier and Lydia Cho offer strategies for coping with dementia-related behaviors.
Dr. Brent P. Forester offers feedback regarding the results of a new Alzheimer’s disease drug trial.
It’s a fact of life that our brains change as we grow older, and as they do, we might notice some subtle differences in the way they work. Aging adults are often increasingly prone to misplacing items or struggling to recall something from the past, for example. These shifts are natural and pose no...
Watch Dr. Brent P. Forester explain how a new Alzheimer’s disease treatment is different than other Alzheimer’s medications.
Dr. Brent P. Forester offers feedback to report findings of a new experimental Alzheimer’s disease clinical drug trial.
Dr. Brent P. Forester comments on the results of a new Alzheimer’s disease drug clinical trial.
In the Media: Promising Alzheimer’s Drug Provides Second Chance for Biogen, and a Debated Theory About the Disease
McLean is part of a new experimental Alzheimer’s disease clinical drug trial.
Dr. Brent P. Forester offers feedback about his Alzheimer’s disease drug trial.
Dr. Brent P. Forester discusses McLean’s clinical trial studying a new, experimental Alzheimer’s disease medication.
Dr. Brent P. Forester warns that as the “baby boomer” population ages, the U.S. will see a rapid increase in the rate of individuals with neurocognitive disorders.
Dr. Brent P. Forester stresses the need for improved screening and reinforcement of care at the earliest stages of dementia and Alzheimer’s disease.
Listen to patients from Dr. Brent P. Forester’s Alzheimer’s disease research project discuss their experience with new drug treatments.
“But I also feel hopeful that this attention, focus, and discussion about Alzheimer’s will bring about a lot of change.” – Dr. Brent P. Forester
Rosalie Rudnick collected friends like she collected Caucasian rugs—easily, passionately, and in large numbers. “The world loved Rosalie,” said Mitch, her husband of 60 years. “She was charming and befriended everyone who came near her.” Even after Alzheimer’s disease robbed her of almost everything...
Dr. Ipsit Vahia and others review the benefits of the COVID-19 vaccine for older adults.
In the Media: I Wrote About Losing My Wife to Younger-Onset Alzheimer’s. This Is What Helped Me Feel Less Alone
Dr. Julie Brody Magid and other experts comment on the grief caregivers struggle with while caring for loved ones with Alzheimer’s disease.
McLean Hospital’s Brent P. Forester, MD, MSc, is heading a new study of a training model to help primary care nurses better care for patients with dementia. Funded by a $54 million grant from the National Institute on Aging (NIA), the research effort is one of two pilot studies by the NIA’s IMPACT...
Dr. Brent Forester, chief of McLean’s Division of Geriatric Psychiatry, shares an update on the evaluation and management of Alzheimer’s Disease and related disorders and what’s new in 2020.